INTENSITY THERAPEUTICS INC (INTS) Stock Income Statement
NASDAQ:INTS - Nasdaq - US45828J1034 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 15.24M | 16.59M | 8.32M | 7.55M | 8.01M | |||
| Research and Development | 9.87M | 10.50M | 4.79M | 5.13M | 5.86M | |||
| Selling, General, and Administrative Expenses | 5.37M | 6.09M | 3.53M | 2.42M | 2.16M | |||
| Operating Income | -15.24M | -16.59M | -8.32M | -7.55M | -8.01M | |||
| Interest Income/Expense | 189.00K | 314.00K | 19.00K | -80.00K | 2.60K | |||
| Other Income/Expense | 35.00K | 3.00K | 24.00K | 48.00K | 115.50K | |||
| Non Recurring Items | N/A | 0.00 | -2.26M | 0.00 | N/A | |||
| Income Before Taxes | -15.01M | -16.27M | -10.54M | -7.58M | -7.90M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -15.01M | -16.27M | -11.86M | -7.58M | -7.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.06 | -1.17 | -0.87 | -0.58 | -0.60 | |||
| Non GAAP EPS | -1.05 | -1.17 | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD